Navigation Links
Agility in Rare Disease and Oncology Clinical Trials – Data Management, New Webinar Hosted by Xtalks
Date:3/19/2019

This free webinar will review strategies for data management in modular and adaptive clinical trials.

Participants will:

  • Learn how to reduce study build times by up to 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster
  • Learn how a cloud platform enables mid-study changes without the need to migrate data – reducing risk and impact on trial success, trial teams, and trial execution
  • Gain insight on how adaptive, lean and flexible operational conduct from a CRO study team enables adaptive data management
  • Review timelines and flexible build process to include challenges experienced and ways to mitigate those challenges
  • Understand how to execute oversight requirements under GCP E2 R2 using online tools

Join Robin Clark, Principal Data Manager, Simbec-Orion Group Ltd and Ralph Johnson, Principal Sales Consultant, Oracle for a live session on Wednesday, April 3, 2019 at 9am EDT (2pm BST/UK). The presentation will be especially helpful for biotech and small/medium-size drug developers working in oncology and rare disease.

For more information or to register for this event, visit Agility in Rare Disease and Oncology Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/agility_in_rare_disease_and_oncology_clinical_trials_data_management_new_webinar_hosted_by_xtalks/prweb16178993.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
2. New MRI method fingerprints tissues and diseases
3. Mutations in VCP gene implicated in a number of neurodegenerative diseases
4. New structural insight into neurodegenerative disease
5. Alzheimer Disease - New Drugs, Markets and Companies - 2013
6. Are Tea and Wine Effective for Preventing Alzheimer’s Disease?
7. Piramal Imaging Announces the Acceptance for Review of [18F] florbetaben by the FDA and EMA for the Visual Detection of beta-amyloid in Alzheimers Disease
8. Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimers Disease Discoveries
9. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
10. NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
11. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2019)... ... April 16, 2019 , ... ... their project partner, the U.S. Army Center for Environmental Health Research (USACEHR), with ... Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the Frederick Innovative ...
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three months ... new kitchen is equipped with updated appliances and modern lighting and fixtures, and will ... , “We’ve seen tremendous growth in the demand for our team-building events ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities ... million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , ... is targeted at female hypoactive sexual dysfunction disorder and is ready to begin phase ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field of ... veterinarians across the United States and Canada since 2004. The primary indications for ... injuries in the dog, cat, and horse. Recently, VetStem teamed up with ...
Breaking Biology Technology:
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake of ... entirely dedicated to Chinese biobanks was launched in July 2018, in an agreement ... Biobank Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered two ...
(Date:3/27/2019)... ... March 27, 2019 , ... NDA Partners Chief Executive Officer ... Health & Pharma Biotechnology Award as the Best Life Sciences Management & Contract ... individuals and companies whose accomplishments have proved evidence of extensive expertise and skills, ...
(Date:3/25/2019)... , ... March 25, 2019 , ... ... Visikol, a contract research organisation focused on advancing drug discovery, have announced a ... imaging. , Tissue clearing methods, which are essential to get a better view ...
Breaking Biology News(10 mins):